{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:16:50Z","timestamp":1789179410286,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ERC AdG CHEMBIOSPHIN","award":["290836"],"award-info":[{"award-number":["290836"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","award":["SFRH\/BD\/72862\/2010"],"award-info":[{"award-number":["SFRH\/BD\/72862\/2010"]}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ymgme.2015.12.006","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T01:31:24Z","timestamp":1450920684000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders"],"prefix":"10.1016","volume":"117","author":[{"given":"Maria J.","family":"Ferraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 R.A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mirzaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"van Roomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelof","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ir\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"S\u00e1 Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman S.","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2015.12.006_bb0005","series-title":"A Treatise on the Chemical Constitution of the Brain","author":"Thudichum","year":"1884"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbalip.2013.10.015","article-title":"Sphingolipids and lysosomal pathologies","volume":"1841","author":"Schulze","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann\u2013Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0020","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann\u2013Pick C disease","volume":"290","author":"Naureckiene","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0025","first-page":"136","article-title":"Additional deficiency of psychosine galactosidase in globoid cell leukodystrophy: an implication to enzyme replacement therapy","volume":"9","author":"Miyatake","year":"1973","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0035","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0040","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0045","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Auray-Blais","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcmd.2015.01.006","article-title":"Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard","volume":"54","author":"Mirzaian","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0060","first-page":"394","article-title":"The twitcher mouse. A model of human globoid cell leukodystrophy (Krabbe\u2019s disease)","volume":"111","author":"Suzuki","year":"1983","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.1996.66031118.x","article-title":"Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe\u2019s disease","volume":"66","author":"Sakai","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-based gene discovery with three unrelated subjects shows SCARB2\/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/ddg062","article-title":"LIMP-2\/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice","volume":"12","author":"Gamp","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0080","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0085","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann\u2013Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0095","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/hmg\/ddr505","article-title":"A novel mouse model of Niemann\u2013Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations","volume":"21","author":"Maue","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0100","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/ejoc.201500025","article-title":"Synthesis of a panel of carbon-13-labelled (glyco)sphingolipids","author":"Wisse","year":"2015","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0105","first-page":"1","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography\u2013tandem mass spectrometry","volume":"59","author":"Gold","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1373\/clinchem.2006.079012","article-title":"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma","volume":"53","author":"Groener","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0005-2760(80)90116-2","article-title":"A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase","volume":"619","author":"Pentchev","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0125","doi-asserted-by":"crossref","first-page":"17674","DOI":"10.1074\/jbc.M313517200","article-title":"Glucosylceramidase mass and subcellular localization are modulated by cholesterol in Niemann\u2013Pick disease type C","volume":"279","author":"Salvioli","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4452","article-title":"Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy","volume":"235","author":"Pavlova","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038520","article-title":"Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism","volume":"7","author":"Lombardo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbadis.2010.09.007","article-title":"Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy","volume":"1812","author":"van Breemen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1194\/jlr.M043802","article-title":"Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis","volume":"55","author":"Gaspar","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0150","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1194\/jlr.D015735","article-title":"A sensitive and specific LC\u2013MS\/MS method for rapid diagnosis of Niemann\u2013Pick C1 disease from human plasma","volume":"52","author":"Jiang","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0155","first-page":"S29","article-title":"Experience with 7-ketocholesterol and ccl18\/parc as surrogated biomarkers in a series of Spanish Niemann\u2013Pick disease type C patients","volume":"114","author":"Cebolla","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0160","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0022-2275(20)31539-X","article-title":"Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry","volume":"42","author":"Whitfield","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2006.04.013","article-title":"Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy","volume":"89","author":"Vedder","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0175","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.112.195685","article-title":"Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine","volume":"60","author":"Rombach","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11916-013-0365-4","article-title":"Fabry disease: a rare cause of neuropathic pain","volume":"17","author":"Biegstraaten","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2015.01.084","article-title":"The Fabry disease-associated lipid lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain","volume":"594","author":"Choi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0190","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/ndt\/gfq306","article-title":"Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy","volume":"26","author":"Sanchez-Ni\u00f1o","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0195","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.3892\/mmr.2015.4010","article-title":"Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease","volume":"12","author":"Shin","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.chroma.2015.01.004","article-title":"Lipidomic profiling of plasma and urine from patients with Gaucher disease during enzyme replacement therapy by nanoflow liquid chromatography\u2013tandem mass spectrometry","volume":"1381","author":"Byeon","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0205","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2009.04.011","article-title":"Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme","volume":"97","author":"Dardis","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0925-4439(94)00075-2","article-title":"Lysosomal storage diseases","volume":"1270","author":"Gieselmann","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.3021","article-title":"The cellular pathology of lysosomal diseases","volume":"226","author":"Cox","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/path.4227","article-title":"B cell lymphoma and myeloma in murine Gaucher\u2019s disease","volume":"231","author":"Pavlova","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.6719111","article-title":"Progressive accumulation of toxic metabolite in a genetic leukodystrophy","volume":"224","author":"Igisu","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0235","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1523\/JNEUROSCI.5597-08.2009","article-title":"Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture","volume":"29","author":"White","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0240","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2003.12.126","article-title":"Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation","volume":"358","author":"Zaka","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/brain\/39.1-2.74","article-title":"A new familial, infantile form of diffuse brain-sclerosis","volume":"39","author":"Krabbe","year":"1916","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2015.12.006_bb0250","first-page":"S75","article-title":"Krabbe disease: an overview","volume":"47","author":"Pastores","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00401-011-0814-2","article-title":"Axonopathy is a compounding factor in the pathogenesis of Krabbe disease","volume":"122","author":"Castelvetri","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0260","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1073\/pnas.0808256105","article-title":"NPC1\/NPC2 function as a tag team duo to mobilize cholesterol","volume":"105","author":"Subramanian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0265","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1016\/S0021-9258(18)91082-3","article-title":"A genetic storage disorder in BALB\/C mice with a metabolic block in esterification of exogenous cholesterol","volume":"259","author":"Pentchev","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","article-title":"Lipids on trial: the search for the offending metabolite in niemann-pick type C disease","volume":"11","author":"Lloyd-Evans","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0005-2760(83)90232-1","article-title":"Studies on sphingomyelinase and beta-glucosidase activities in Niemann\u2013Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates","volume":"752","author":"Besley","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","article-title":"Biochemical studies in Niemann\u2013Pick disease. I. Major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114669","article-title":"Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann\u2013Pick disease type C in a retrospective study","volume":"9","author":"Welford","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2015.12.006_bb0290","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1093\/hmg\/ddt284","article-title":"Genetic screening for Niemann\u2013Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study","volume":"22","author":"Bauer","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0295","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann\u2013Pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2015.12.006_bb0300","doi-asserted-by":"crossref","first-page":"56ra81","DOI":"10.1126\/scitranslmed.3001417","article-title":"Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann\u2013Pick C1 disease","volume":"2","author":"Porter","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215300901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215300901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T17:22:33Z","timestamp":1653931353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719215300901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1096719215300901"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.12.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}